在严重喘中小呼吸道功能障碍:当前的治疗方法和未来的方向
Nishan Deng1, Yunyan Xianyu1, Yaqing Xu2
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Journal of the Formosan Medical Association = Taiwan yi zhi
|February 1, 2025
概括
严重的喘显著影响生活质量和医疗保健成本. 针对小呼吸道功能障碍对于更好地控制喘和管理严重喘患者的恶化至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 严重的喘带来了重大挑战,包括增加死亡率,降低生活质量和高医疗费用.
- 小气道 (直径小于2毫米) 占肺体积的98.8%,对调节气道阻力至关重要.
- 小气道功能障碍存在于所有喘严重程度,但在严重情况下最为明显.
研究的目的:
- 突出小气道功能障碍在严重喘中的关键作用.
- 为了强调小呼吸道功能障碍严重程度和喘不良结果之间的相关性.
- 倡导针对小呼吸道的治疗策略,以改善严重喘管理.
主要方法:
- 关于喘病理生理学和治疗的最新研究和临床数据的综述.
- 分析小气道与整体喘严重程度之间的关系.
- 小气道功能障碍与喘控制和恶化频率的相关性分析.
主要成果:
- 小呼吸道功能障碍是喘的常见特征,随着疾病的严重程度而升级.
- 增加小呼吸道功能障碍的严重程度直接与较差的喘控制有关.
- 较大的小呼吸道功能障碍与更高频率的喘恶化有关.
结论:
- 小气道功能障碍是严重喘不良结果的关键驱动因素.
- 专注于小呼吸道的治疗干预措施对于有效的严重喘管理至关重要.
- 解决小呼吸道功能障碍为改善患者生活质量和减少医疗保健负担提供了一个有希望的途径.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
344
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
344
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
343
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
233
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233
COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


